 | • レポートコード：MR2211MG10848 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、悪性貧血診断及び治療のグローバル市場規模と予測を記載しています。・悪性貧血診断及び治療のグローバル市場：売上、2017年-2022年、2023年-2028年 ・悪性貧血診断及び治療のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 悪性貧血診断及び治療のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「血算検査」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 悪性貧血診断及び治療のグローバル主要企業は、Pfizer, Inc.、Daiichi Sankyo Co., Ltd.、The Synergy Company、Endo Pharmaceuticals Plc.、GlaxoSmithKline Plc.、DSM Nutritional Products AG、Monobind, Inc.、Bio-Rad Laboratories, Inc.、Premier Research Labs、Cleveland HeartLab, Inc.、Trinity Biotech Plc.、American Regent, Inc.、Emisphere Technologies, Inc.、BioVision, Inc.、Guardian Healthcarなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、悪性貧血診断及び治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の悪性貧血診断及び治療市場：タイプ別、2017年-2022年、2023年-2028年 世界の悪性貧血診断及び治療市場：タイプ別市場シェア、2021年 ・血算検査、ビタミンB-12欠乏症検査、内因子欠乏症検査 世界の悪性貧血診断及び治療市場：用途別、2017年-2022年、2023年-2028年 世界の悪性貧血診断及び治療市場：用途別市場シェア、2021年 ・病院、診療所、その他 世界の悪性貧血診断及び治療市場：地域・国別、2017年-2022年、2023年-2028年 世界の悪性貧血診断及び治療市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における悪性貧血診断及び治療のグローバル売上、2017年-2022年 ・主要企業における悪性貧血診断及び治療のグローバル売上シェア、2021年 ・主要企業における悪性貧血診断及び治療のグローバル販売量、2017年-2022年 ・主要企業における悪性貧血診断及び治療のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer, Inc.、Daiichi Sankyo Co., Ltd.、The Synergy Company、Endo Pharmaceuticals Plc.、GlaxoSmithKline Plc.、DSM Nutritional Products AG、Monobind, Inc.、Bio-Rad Laboratories, Inc.、Premier Research Labs、Cleveland HeartLab, Inc.、Trinity Biotech Plc.、American Regent, Inc.、Emisphere Technologies, Inc.、BioVision, Inc.、Guardian Healthcar ************************************************************* ・調査・分析レポートの概要 悪性貧血診断及び治療市場の定義 市場セグメント 世界の悪性貧血診断及び治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の悪性貧血診断及び治療市場規模 世界の悪性貧血診断及び治療市場規模：2021年 VS 2028年 世界の悪性貧血診断及び治療市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの悪性貧血診断及び治療の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の悪性貧血診断及び治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：血算検査、ビタミンB-12欠乏症検査、内因子欠乏症検査 悪性貧血診断及び治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 悪性貧血診断及び治療の用途別グローバル売上・予測 ・地域別市場分析 地域別悪性貧血診断及び治療市場規模 2021年と2028年 地域別悪性貧血診断及び治療売上・予測 北米市場 - アメリカの悪性貧血診断及び治療市場規模2017年-2028年 - カナダの悪性貧血診断及び治療市場規模2017年-2028年 - メキシコの悪性貧血診断及び治療市場規模2017年-2028年 ヨーロッパ市場 - ドイツの悪性貧血診断及び治療市場規模2017年-2028年 - フランスの悪性貧血診断及び治療市場規模2017年-2028年 - イギリスの悪性貧血診断及び治療市場規模2017年-2028年 - イタリアの悪性貧血診断及び治療市場規模2017年-2028年 - ロシアの悪性貧血診断及び治療市場規模2017年-2028年 アジア市場 - 中国の悪性貧血診断及び治療市場規模2017年-2028年 - 日本の悪性貧血診断及び治療市場規模2017年-2028年 - 韓国の悪性貧血診断及び治療市場規模2017年-2028年 - 東南アジアの悪性貧血診断及び治療市場規模2017年-2028年 - インドの悪性貧血診断及び治療市場規模2017年-2028年 南米市場 - ブラジルの悪性貧血診断及び治療市場規模2017年-2028年 - アルゼンチンの悪性貧血診断及び治療市場規模2017年-2028年 中東・アフリカ市場 - トルコの悪性貧血診断及び治療市場規模2017年-2028年 - イスラエルの悪性貧血診断及び治療市場規模2017年-2028年 - サウジアラビアの悪性貧血診断及び治療市場規模2017年-2028年 - UAEの悪性貧血診断及び治療市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer, Inc.、Daiichi Sankyo Co., Ltd.、The Synergy Company、Endo Pharmaceuticals Plc.、GlaxoSmithKline Plc.、DSM Nutritional Products AG、Monobind, Inc.、Bio-Rad Laboratories, Inc.、Premier Research Labs、Cleveland HeartLab, Inc.、Trinity Biotech Plc.、American Regent, Inc.、Emisphere Technologies, Inc.、BioVision, Inc.、Guardian Healthcar ... |
This report contains market size and forecasts of Pernicious Anemia Diagnosis and Treatment in Global, including the following market information:
Global Pernicious Anemia Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pernicious Anemia Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Complete Blood Count Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pernicious Anemia Diagnosis and Treatment include Pfizer, Inc., Daiichi Sankyo Co., Ltd., The Synergy Company, Endo Pharmaceuticals Plc., GlaxoSmithKline Plc., DSM Nutritional Products AG, Monobind, Inc., Bio-Rad Laboratories, Inc. and Premier Research Labs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pernicious Anemia Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pernicious Anemia Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pernicious Anemia Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)
Complete Blood Count Test
Vitamin B-12 Deficiency Test
Intrinsic Factor Deficiency Test
Global Pernicious Anemia Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pernicious Anemia Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Pernicious Anemia Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pernicious Anemia Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pernicious Anemia Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pernicious Anemia Diagnosis and Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Daiichi Sankyo Co., Ltd.
The Synergy Company
Endo Pharmaceuticals Plc.
GlaxoSmithKline Plc.
DSM Nutritional Products AG
Monobind, Inc.
Bio-Rad Laboratories, Inc.
Premier Research Labs
Cleveland HeartLab, Inc.
Trinity Biotech Plc.
American Regent, Inc.
Emisphere Technologies, Inc.
BioVision, Inc.
Guardian Healthcare Services Pvt. Ltd.
Laboratory Corporation of America Holdings
Pharmacosmos A/S
Pharmavite, LLC
Swanson Health Products
1 Introduction to Research & Analysis Reports
1.1 Pernicious Anemia Diagnosis and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pernicious Anemia Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pernicious Anemia Diagnosis and Treatment Overall Market Size
2.1 Global Pernicious Anemia Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Pernicious Anemia Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pernicious Anemia Diagnosis and Treatment Players in Global Market
3.2 Top Global Pernicious Anemia Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Pernicious Anemia Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pernicious Anemia Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pernicious Anemia Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pernicious Anemia Diagnosis and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Pernicious Anemia Diagnosis and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Pernicious Anemia Diagnosis and Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Pernicious Anemia Diagnosis and Treatment Market Size Markets, 2021 & 2028
4.1.2 Complete Blood Count Test
4.1.3 Vitamin B-12 Deficiency Test
4.1.4 Intrinsic Factor Deficiency Test
4.2 By Type – Global Pernicious Anemia Diagnosis and Treatment Revenue & Forecasts
4.2.1 By Type – Global Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2022
4.2.2 By Type – Global Pernicious Anemia Diagnosis and Treatment Revenue, 2023-2028
4.2.3 By Type – Global Pernicious Anemia Diagnosis and Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pernicious Anemia Diagnosis and Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Pernicious Anemia Diagnosis and Treatment Revenue & Forecasts
5.2.1 By Application – Global Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2022
5.2.2 By Application – Global Pernicious Anemia Diagnosis and Treatment Revenue, 2023-2028
5.2.3 By Application – Global Pernicious Anemia Diagnosis and Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Pernicious Anemia Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region – Global Pernicious Anemia Diagnosis and Treatment Revenue & Forecasts
6.2.1 By Region – Global Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2022
6.2.2 By Region – Global Pernicious Anemia Diagnosis and Treatment Revenue, 2023-2028
6.2.3 By Region – Global Pernicious Anemia Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2028
6.3.2 US Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.3.3 Canada Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.3.4 Mexico Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2028
6.4.2 Germany Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4.3 France Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4.4 U.K. Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4.5 Italy Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4.6 Russia Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.4.8 Benelux Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2028
6.5.2 China Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.5.3 Japan Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.5.4 South Korea Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.5.6 India Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2028
6.6.2 Brazil Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.6.3 Argentina Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Pernicious Anemia Diagnosis and Treatment Revenue, 2017-2028
6.7.2 Turkey Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.7.3 Israel Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
6.7.5 UAE Pernicious Anemia Diagnosis and Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.1.4 Pfizer, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.1.5 Pfizer, Inc. Key News
7.2 Daiichi Sankyo Co., Ltd.
7.2.1 Daiichi Sankyo Co., Ltd. Corporate Summary
7.2.2 Daiichi Sankyo Co., Ltd. Business Overview
7.2.3 Daiichi Sankyo Co., Ltd. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.2.4 Daiichi Sankyo Co., Ltd. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.2.5 Daiichi Sankyo Co., Ltd. Key News
7.3 The Synergy Company
7.3.1 The Synergy Company Corporate Summary
7.3.2 The Synergy Company Business Overview
7.3.3 The Synergy Company Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.3.4 The Synergy Company Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.3.5 The Synergy Company Key News
7.4 Endo Pharmaceuticals Plc.
7.4.1 Endo Pharmaceuticals Plc. Corporate Summary
7.4.2 Endo Pharmaceuticals Plc. Business Overview
7.4.3 Endo Pharmaceuticals Plc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.4.4 Endo Pharmaceuticals Plc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.4.5 Endo Pharmaceuticals Plc. Key News
7.5 GlaxoSmithKline Plc.
7.5.1 GlaxoSmithKline Plc. Corporate Summary
7.5.2 GlaxoSmithKline Plc. Business Overview
7.5.3 GlaxoSmithKline Plc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.5.4 GlaxoSmithKline Plc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Plc. Key News
7.6 DSM Nutritional Products AG
7.6.1 DSM Nutritional Products AG Corporate Summary
7.6.2 DSM Nutritional Products AG Business Overview
7.6.3 DSM Nutritional Products AG Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.6.4 DSM Nutritional Products AG Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.6.5 DSM Nutritional Products AG Key News
7.7 Monobind, Inc.
7.7.1 Monobind, Inc. Corporate Summary
7.7.2 Monobind, Inc. Business Overview
7.7.3 Monobind, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.7.4 Monobind, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.7.5 Monobind, Inc. Key News
7.8 Bio-Rad Laboratories, Inc.
7.8.1 Bio-Rad Laboratories, Inc. Corporate Summary
7.8.2 Bio-Rad Laboratories, Inc. Business Overview
7.8.3 Bio-Rad Laboratories, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.8.4 Bio-Rad Laboratories, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.8.5 Bio-Rad Laboratories, Inc. Key News
7.9 Premier Research Labs
7.9.1 Premier Research Labs Corporate Summary
7.9.2 Premier Research Labs Business Overview
7.9.3 Premier Research Labs Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.9.4 Premier Research Labs Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.9.5 Premier Research Labs Key News
7.10 Cleveland HeartLab, Inc.
7.10.1 Cleveland HeartLab, Inc. Corporate Summary
7.10.2 Cleveland HeartLab, Inc. Business Overview
7.10.3 Cleveland HeartLab, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.10.4 Cleveland HeartLab, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.10.5 Cleveland HeartLab, Inc. Key News
7.11 Trinity Biotech Plc.
7.11.1 Trinity Biotech Plc. Corporate Summary
7.11.2 Trinity Biotech Plc. Business Overview
7.11.3 Trinity Biotech Plc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.11.4 Trinity Biotech Plc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.11.5 Trinity Biotech Plc. Key News
7.12 American Regent, Inc.
7.12.1 American Regent, Inc. Corporate Summary
7.12.2 American Regent, Inc. Business Overview
7.12.3 American Regent, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.12.4 American Regent, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.12.5 American Regent, Inc. Key News
7.13 Emisphere Technologies, Inc.
7.13.1 Emisphere Technologies, Inc. Corporate Summary
7.13.2 Emisphere Technologies, Inc. Business Overview
7.13.3 Emisphere Technologies, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.13.4 Emisphere Technologies, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.13.5 Emisphere Technologies, Inc. Key News
7.14 BioVision, Inc.
7.14.1 BioVision, Inc. Corporate Summary
7.14.2 BioVision, Inc. Business Overview
7.14.3 BioVision, Inc. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.14.4 BioVision, Inc. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.14.5 BioVision, Inc. Key News
7.15 Guardian Healthcare Services Pvt. Ltd.
7.15.1 Guardian Healthcare Services Pvt. Ltd. Corporate Summary
7.15.2 Guardian Healthcare Services Pvt. Ltd. Business Overview
7.15.3 Guardian Healthcare Services Pvt. Ltd. Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.15.4 Guardian Healthcare Services Pvt. Ltd. Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.15.5 Guardian Healthcare Services Pvt. Ltd. Key News
7.16 Laboratory Corporation of America Holdings
7.16.1 Laboratory Corporation of America Holdings Corporate Summary
7.16.2 Laboratory Corporation of America Holdings Business Overview
7.16.3 Laboratory Corporation of America Holdings Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.16.4 Laboratory Corporation of America Holdings Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.16.5 Laboratory Corporation of America Holdings Key News
7.17 Pharmacosmos A/S
7.17.1 Pharmacosmos A/S Corporate Summary
7.17.2 Pharmacosmos A/S Business Overview
7.17.3 Pharmacosmos A/S Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.17.4 Pharmacosmos A/S Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.17.5 Pharmacosmos A/S Key News
7.18 Pharmavite, LLC
7.18.1 Pharmavite, LLC Corporate Summary
7.18.2 Pharmavite, LLC Business Overview
7.18.3 Pharmavite, LLC Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.18.4 Pharmavite, LLC Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.18.5 Pharmavite, LLC Key News
7.19 Swanson Health Products
7.19.1 Swanson Health Products Corporate Summary
7.19.2 Swanson Health Products Business Overview
7.19.3 Swanson Health Products Pernicious Anemia Diagnosis and Treatment Major Product Offerings
7.19.4 Swanson Health Products Pernicious Anemia Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.19.5 Swanson Health Products Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer